Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-07-27
1998-06-16
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514563, A61K 31335, A61K 31195
Patent
active
057671486
ABSTRACT:
Pharmaceutical/dermatological compositions comprising (a) at least one first ligand displaying selective activity for the RXR receptors and (b) at least one second ligand displaying selective activity for the RAR-.alpha. receptor, are useful for modulating the proliferation and/or differentiation of HL-60 type cells, in particular for the systemic treatment of acute promyelocytic leukemia.
REFERENCES:
Proc Annu Meet Am Assoc Cancer Res; 33:A565-6 15-07-92, Sporn MB et al, p. 566, col. 1.
Blood, 84 (2) 1994, 446-452, Dawson et al, p. 448, Col. 2, Line 3, p. 450, Col. 2.
Nucleic Acids Res, Mar. 11, 1993, 21 (5), P1231-7, England, Schrader et al.
New Engl. J. Med. 1993, 329/3 (177-189), USA, p. 186, Col. 1, Line 3, Col. 2.
Cathelineau Christine
Demarchez Michel
Lenoir-Viale Marie-Cecile
Michel Serge
Centre International de Recherches Dermatologiques Galderma
Goldberg Jerome D.
LandOfFree
Synergistic therapeutic compositions comprising at least one lig does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synergistic therapeutic compositions comprising at least one lig, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergistic therapeutic compositions comprising at least one lig will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1726455